Reaction
Fracture Nonunion reporting signals
As of the last recalculation, Fracture Nonunion appears in 1,358 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 418.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 911 | 418.3 | 422.2 |
| Risedronate Sodium | 122 | 66.0 | 66.3 |
| Ascorbic Acid | 46 | 31.3 | 31.4 |
| Zoledronic Acid | 59 | 23.5 | 23.5 |
| Alendronate Sodium Tablet | 27 | 22.8 | 22.8 |
| Raloxifene Hydrochloride | 19 | 20.2 | 20.2 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 29 | 19.2 | 19.2 |
| Vitamin E | 31 | 15.4 | 15.5 |
| Teriparatide | 71 | 10.1 | 10.1 |
| Conjugated Estrogens | 37 | 10.0 | 10.0 |
| Estrogens, Conjugated | 37 | 9.8 | 9.8 |
| Loratadine And Pseudoephedrine Sulfate | 4 | 7.7 | 7.7 |
| Asfotase Alfa | 4 | 6.1 | 6.1 |
| Abaloparatide | 10 | 5.2 | 5.2 |